Nipa-akàn / itọju / awọn oogun / awọ-ara

Awọn oogun ti a fọwọsi fun Arun Ara

Oju-iwe yii ṣe atokọ awọn oogun aarun ti a fọwọsi nipasẹ Ounje ati Oogun Ounjẹ (FDA) fun aarun awọ-ara, pẹlu awọn oogun fun kaarunoma basal, melanoma, ati carcinoma cell merkel. Atokọ naa pẹlu awọn orukọ jeneriki ati awọn orukọ iyasọtọ. Awọn orukọ oogun lo sopọ si awọn akopọ Alaye Oogun Alaye ti NCI. Awọn oogun ti o le lo ninu aarun awọ ara ko le ṣe atokọ nibi.

LORI Oju-iwe yii

• Awọn oogun ti a fọwọsi fun Carcinoma Basal Cell

• Awọn oogun ti a fọwọsi fun Ẹka Alakan Ẹjẹ Cutaneous

• Awọn oogun ti a fọwọsi fun Melanoma

• Awọn oogun ti a fọwọsi fun Carcinoma Cell Cell

Awọn oogun ti a fọwọsi fun Carcinoma Basal Cell

Aldara (Imiquimod)

Efudex (Fluorouracil - Akori)

Erivedge (Vismodegib)

5-FU (Fluorouracil - Akori)

Fluorouracil - Kokoro

Imiquimod

Odomzo (Sonidegib)

Sonidegib

Vismodegib

Awọn oogun ti a fọwọsi fun Ẹka Alakan Ẹjẹ Cutaneous

Cemiplimab-rwlc

Libtayo (Cemiplimab-rwlc)

Awọn oogun ti a fọwọsi fun Melanoma

Aldesleukin

Cobimetinib

Cotellic (Cobimetinib)

Dabrafenib

Dacarbazine

DTIC-Dome (Dacarbazine)

IL-2 (Aldesleukin)

Imlygic (Talimogene Laherparepvec)

Interleukin-2 (Aldesleukin)

Intron A (Recombinant Interferon Alfa-2b)

Ipilimumab

Keytruda (Pembrolizumab)

Mekinist (Trametinib)

Nivolumab

Opdivo (Nivolumab)

Peginterferon Alfa-2b

Pembrolizumab

Proleukin (Aldesleukin)

Recombinant Interferon Alfa-2b

Sylatron (Peginterferon Alfa-2b)

Tafinlar (Dabrafenib)

Talimogene Laherparepvec

Trametinib

Vemurafenib

Yervoy (Ipilimumab)

Zelboraf (Vemurafenib)

Awọn oogun ti a fọwọsi fun Carcinoma Cell Cell

Avelumab

Bavencio (Avelumab)

Keytruda (Pembrolizumab)

Pembrolizumab